Rate of Change in Cardiac Magnetic Resonance Imaging Measures Is Associated With Death in Duchenne Muscular Dystrophy
- PMID: 38686878
- PMCID: PMC11179921
- DOI: 10.1161/JAHA.123.032960
Rate of Change in Cardiac Magnetic Resonance Imaging Measures Is Associated With Death in Duchenne Muscular Dystrophy
Abstract
Background: Cardiovascular disease is the leading cause of death among patients with Duchenne muscular dystrophy (DMD). Identifying patients at risk of early death could allow for increased monitoring and more intensive therapy. Measures that associate with death could serve as surrogate outcomes in clinical trials.
Methods and results: Duchenne muscular dystrophy subjects prospectively enrolled in observational studies were included. Models using generalized least squares were used to assess the difference of cardiac magnetic resonance measurements between deceased and alive subjects. A total of 63 participants underwent multiple cardiac magnetic resonance imaging and were included in the analyses. Twelve subjects (19.1%) died over a median follow-up of 5 years (interquartile range, 3.1-7.0). Rate of decline in left ventricular ejection fraction was faster in deceased than alive subjects (P<0.0001). Rate of increase in indexed left ventricular end-diastolic (P=0.0132) and systolic (P<0.0001) volumes were higher in deceased subjects. Faster worsening in midcircumferential strain was seen in deceased subjects (P=0.049) while no difference in global circumferential strain was seen. The rate of increase in late gadolinium enhancement, base T1, and mid T1 did not differ between groups.
Conclusions: Duchenne muscular dystrophy death is associated with the rate of change in left ventricular ejection fraction, midcircumferential strain, and ventricular volumes. Aggressive medical therapy to decrease the rate of progression may improve the mortality rate in this population. A decrease in the rate of progression may serve as a valid surrogate outcome for therapeutic trials.
Keywords: follow‐up studies; gadolinium; global longitudinal strain; magnetic resonance imaging; muscular dystrophies.
Figures
Similar articles
-
Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging.BMC Cardiovasc Disord. 2022 Jun 9;22(1):260. doi: 10.1186/s12872-022-02688-5. BMC Cardiovasc Disord. 2022. PMID: 35681116 Free PMC article.
-
Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2023 Feb 16;25(1):14. doi: 10.1186/s12968-023-00922-3. J Cardiovasc Magn Reson. 2023. PMID: 36793101 Free PMC article.
-
Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy.Circ Heart Fail. 2023 Aug;16(8):e010040. doi: 10.1161/CIRCHEARTFAILURE.122.010040. Epub 2023 Jun 8. Circ Heart Fail. 2023. PMID: 37288563 Free PMC article.
-
Value of Cardiac T1-Mapping and ECV Quantification in Duchenne Muscular Dystrophy (DMD): Case Report, Typical Imaging Findings and Review of the Literature.Rofo. 2017 Jan;189(1):75-77. doi: 10.1055/s-0042-116685. Epub 2016 Dec 6. Rofo. 2017. PMID: 27923261 Review. No abstract available.
-
Risk Factors for Cerebral Infarction in Duchenne Muscular Dystrophy: Review With our 2 Cases.J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2453-2458. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.023. Epub 2019 Jul 13. J Stroke Cerebrovasc Dis. 2019. PMID: 31311695 Review.
References
-
- Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, Wilkinson JD, Orav EJ, Cuniberti L, Salbert BA, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry. Am Heart J. 2008;155:998–1005. doi: 10.1016/j.ahj.2008.01.018 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
